FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
S SENSIBLE BIOTECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/28/2026
Trademark type
Combined
Nice classes
1, 5, 35, 42
Filing date
06/01/2023
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
SK
Examiner
FENNESSY, EDWARD JOHN
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "SENSIBLE BIOTECHNOLOGIES" appearing beneath a stylized uppercase letter "S" with two short parallel lines inside the curvature of the upper and lower portion of the letter, around which appears a circle composed of seventy-two dashed lines.
Holders and representatives
Holders
S. O. (pessoa física)
Representatives
Marek Krizka TRAMA LEGAL, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for use in industry; cell culture media for use in the biotechnological industry for scientific and research use; cell culture reagents for scientific and research use; biological preparation for use in cell cultures other than for medical or veterinary use; chemical for use in biotechnological manufacturing processes for use in molecular separation processes other than for medical or veterinary use; chemical for use in biotechnological product development for use in molecular separation processes other than for medical or veterinary use; cultures of microbiotic organismsother than for medical use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; cell culture media for microbiology for scientific and research purposes; biological preparations for use in science; biological preparations for use in industry; biological preparations for use in cell culturesother than for medical or veterinary purposes
Class 5
Biotechnological preparations for use in cell cultures for medical purposes; cells for medical use; living cells for medical use
Class 35
Retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies
Class 42
Biotechnology testing of pharmaceutical preparations for gene therapypharmaceuticalschemicals and cell culture media; consulting services in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; writing of computer programs for biotechnological applications; development of measuring probes for biotechnological applications; research and development of new products in the field of biotechnology; designing equipment for the biotechnology industry; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research in the field of cell engineering technology; cell culture services for scientific and research purposesfor others; analysis in the field of molecular biologymessenger RNA analysis to diagnose and treat diseases like COVID-19influenzaRSVZikaCMVHIVmelanomalung cancerpancreatic cancercystic fibrosispropionic acidemiamethylmalonic acidemiaFabry diseaseGaucher diseaseheart diseasemultiple sclerosisType 1 diabetesrheumatoid arthritisvarious allergies; research relating to molecular sciences; contract research services relating to molecular sciences; microbiological testing of cell culture mediaDNA and RNA to diagnose and treat diseases like COVID-19influenzaRSVZikaCMVHIVmelanomalung cancerpancreatic cancercystic fibrosispropionic acidemiamethylmalonic acidemiaFabry diseaseGaucher diseaseheart diseasemultiple sclerosisType 1 diabetesrheumatoid arthritisvarious allergies medical research; pharmaceutical research; biochemical analyses; biochemical research and development services in the field of messenger RNA to diagnose and treat diseases like COVID-19influenzaRSVZikaCMVHIVmelanomalung cancerpancreatic cancercystic fibrosispropionic acidemiamethylmalonic acidemiaFabry diseaseGaucher diseaseheart diseasemultiple sclerosisType 1 diabetesrheumatoid arthritisvarious allergies; laboratory analyses of materialsDNA and RNA materials to diagnose and treat diseases like COVID-19influenzaRSVZikaCMVHIVmelanomalung cancerpancreatic cancercystic fibrosispropionic acidemiamethylmalonic acidemiaFabry diseaseGaucher diseaseheart diseasemultiple sclerosisType 1 diabetesrheumatoid arthritisvarious allergies; biochemical research; biochemical analysis; biochemical research and development; biological laboratory research; chemical laboratory research; laboratory testing of materials; laboratory research in the field of chemistry; DNA testing for scientific research purposesDNA screeningdetermining DNA mutations; chemical laboratory services; biological research laboratory services; genetic engineering services in the field of genetic diseases; chemical analysis; scientific research in the field of genetics and genetic engineering; research and development in the field of microorganisms and cells
Publications
History of USPTO decisions and trademark events.
45 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/12/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/12/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/12/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/10/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2026
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
07/07/2025
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
07/07/2025
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
07/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/23/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/04/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/29/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/11/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/11/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/23/2024
GNFR
FINAL REFUSAL E-MAILED
10/23/2024
CNFR
FINAL REFUSAL WRITTEN
10/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/10/2024
RFNT
REFUSAL PROCESSED BY IB
04/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/19/2024
RFRR
REFUSAL PROCESSED BY MPU
03/18/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/25/2024
CNRT
NON-FINAL ACTION WRITTEN
02/24/2024
DOCK
ASSIGNED TO EXAMINER
02/23/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/12/2023
Continuous trademark protection
Get notified about every new filing that threatens S SENSIBLE BIOTECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.